Division of Dermatology

Dermatopharmacology Fellowship

Program Leadership 

Director: Holly Kanavy, MD

The Fellowship Experience

The Albert Einstein/Montefiore Dermatology Clinical Research Fellowship Program provides an in-depth experience in the clinical research related to dermatology.The program offers clinical research experience tailored to each fellow’s needs. Working with academic clinicians, fellows gain clinical skills that serve them and their patients in the future.  

Fellowship Goals

To develop skills in the planning, implementation and conduct of clinical trials
To develop skills in the evaluation, management and prevention of dermatologic diseases, and data analysis
To gain experience with these diseases in the clinical research (practice) setting
To develop effective interpersonal and communication skills with study patients, their families, members of the research staff, and pharmaceutical sponsors in the clinical research setting
To become familiar with regulations at the federal and state level that govern current approaches and tools for conducting clinical trials
To develop an understanding of the drug development process, and good clinical practices  

Prior Research Studies and Clinical Trials 

10-Year, Post-marketing, Observational, Registry to Assess Long Term Safety of HUMIRA®
(Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (Ps)
A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Induction Dosing
Period Followed by a Randomized Maintenance Dosing Period and a Long-Term Extension Period to Evaluate the Efficacy a Safety of LY2439821 in Patients with Moderate-to-Severe Plaque Psoriasis
A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa PIONEER (OPEN-LABEL EXTENSION)
A Phase 3b, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate a “Subject-tailored” Maintenance Dosing Approach in Subjects with Moderate-to-Severe Plaque Psoriasis
An Observational, Multicenter Disease Registry to Evaluate Clinical Practice Trends and Outcomes in Adult Patients with Hidradenitis Suppurativa – UNITE
A Multicenter, Randomized, Double-blind, Parallel group, Vehicle-controlled study of the Safety
and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 years of age) with Mild-to-Moderate Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrenosum
A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated with Valchlor®
An Open-label Phase II Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients with Persistent, Moderate-to-Severe Atopic Dermatitis
Impact of Hidradenitis Suppurativa on Quality of Life Functions: A Cross-Sectional Analysis of 400 Patients
Development and Maintenance of a National Registry for Patients with Hidradenitis Suppurativa
Randomized Pilot Study Investigating the Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum


Holly Kanavy, DO
Phone: (718) 920-2680


About the Division

Division of Dermatology Overview 


Contact the Division

Madeline Solis

Divisional Administrator

Dermatology and Allergy

Phone: (718) 920-8154


Karen Grant, MS
Residency Program Administrator
3411 Wayne Ave,
2nd Floor,
Bronx, NY, 10467
Phone: (718) 920-2680 

Click here to log in